Roberto Barriales-Villa
@rbarvil
Born in Mieres del Camino (Asturias); Cardiologist; Inherited Cardiovascular Diseases - Genetics at Complexo Hospitalario Universitario A Coruña #SomosCHUAC
ID:1055505550740520961
25-10-2018 17:05:08
1,2K Tweets
912 Followers
344 Following
Llegó el día!! mañana desde las 9 am arrancamos con fenocopias #ATTR #Fabry y luego una mesa de #HCM con expertos 🇦🇷🇪🇸🇬🇧 en el tema. IMPERDIBLE Juan Pablo Kaski Roberto Barriales-Villa
👉Excelentes perspectivas para los pacientes con MCH obstructiva! 👉Esperemos que pronto podamos tener comercializados mavacamten y aficamten en🇪🇸!!! Aimee Emch Sección Cardiopatías Familiares y Genética CV SEC Soc Esp Cardiología
Congratulations to the Cytokinetics team! #Aficamten impressive results published in the top Medical Journal. New Era for patients with Hypertrophic CM, thanks to Mavacamten & Aficamten nejm.org/doi/abs/10.105…
The #SEQUOIA #HCM trial results are here - Placebo-controlled trial of #aficamten in #obstructive #HCM
3 presentations in 3 threads - follow along
This is the first presentation by Martin Maron, MD sharing the primary results
Follow along #CardioTwitter #HeartFailure2024
The SEQUOIA-HCM trial is just published NEJM showing significantly greater improvement in peak O2 uptake in symptomatic obstructive #HCM patients on Aficamten compared with placebo
Congratulations, Dr. Martin Maron, MD and Dr. Ahmad Masri
#HOCM #cardiomyopathy #CardioTwitter
Presented at #HeartFailure2024 :
Among patients with symptomatic obstructive hypertrophic cardiomyopathy, treatment with aficamten led to a greater increase in peak oxygen consumption than placebo at 6 months. Full SEQUOIA-HCM phase 3 trial results: nej.md/3wmDzyl
.Martin Maron, MD discusses aficamten for the treatment of symptomatic obstructive hypertrophic cardiomyopathy with Amina
Watch their #HFASnacks 🤗
#HFA_ESC #HeartFailure2024 #20yearsHFA
Una nueva alternativa p/pac. con MCH obstructiva
❗️282 🧑🤝🧑 recibieron aficamten vs placebo por 24 sem
❗️End point 1rio: Mejoría en el consumo max de O2
Otro paso en la MCH, realmente creen que lo vamos a poder utilizar? SIAC-Consejo de Miocardiopatías Consejo de cardiología genética de la @SAC_54 Roberto Barriales-Villa
nejm.org/doi/full/10.10…
Aficamten for the treatment of symptomatic obstructive hypertrophic #cardiomyopathy - SEQUOIA-HCM study.
#HeartFailure2024 #HFA_ESC
Here are the primary results of #aficamten in NEJM
nejm.org/doi/full/10.10…
#HeartFailure2024 #CardioTwitter
👉Agree! 👉Mainly in phenocopies (late onset Fabry disease variants, some ATTR-CA variants, PRKAG2…..)👍Sección Cardiopatías Familiares y Genética CV SEC